Therapeutics & Vaccines
Lipid-Peptide Fusion Inhibitors As SARS-CoV-2 Antivirals
WARF: P200290US02
Inventors: Samuel Gellman, Anne Moscona, Matteo Porotto, Victor Outlaw, Zhen Yu
The Invention
UW Madison researchers and collaborators present a method of treating COVID-19 with lipid- peptide fusion antiviral therapy. Also described is a composition and method of treating Ebola with lipid-peptide fusion antiviral therapy.
Additional Information
For More Information About the Inventors
For current licensing status, please contact Rafael Diaz at [javascript protected email address] or 608-960-9847